e-learning
resources
Berlin 2008
Tuesday, 07.10.2008
Clinical aspects of interstitial lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Vital capacity forced (VCF) and PaO2 to evaluate the evolution of the hypersensivity pneumonia
M. A. Sanchez Mecatl, J. G. Carrillo Hernandez, A. Estrada Garrido, M. E. Mejia Avila (Distrito Federal, Mexico)
Source:
Annual Congress 2008 - Clinical aspects of interstitial lung disease
Session:
Clinical aspects of interstitial lung disease
Session type:
Thematic Poster Session
Number:
3457
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. A. Sanchez Mecatl, J. G. Carrillo Hernandez, A. Estrada Garrido, M. E. Mejia Avila (Distrito Federal, Mexico). Vital capacity forced (VCF) and PaO2 to evaluate the evolution of the hypersensivity pneumonia. Eur Respir J 2008; 32: Suppl. 52, 3457
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion on genetics in pulmonary fibrosis
Related content which might interest you:
The acceptability criterion for the difference between the forced inspiratory vital capacity (FIVC) and the forced vital capacity (FVC) are too strict?
Source: Virtual Congress 2021 – Future advances in respiratory physiology
Year: 2021
Forced vital capacity (FVC) decline in idiopathic pulmonary fibrosis (IPF) – modelling the myth
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019
Is the forced expiratory volume in 6 seconds (FEV
6
) a more reproducible and accurate measurement than forced vital capacity (FVC) in obstructive and normal/restrictive patients
Source: Eur Respir J 2001; 18: Suppl. 33, 13s
Year: 2001
Lung function measurement in respiratory diseases: mechanisms
Source: Annual Congress 2006 - PG5 - Respiratory physiology: interpreting lung function in health and disease
Year: 2006
Forced vital capacity and forced expiratory volume in six seconds as predictors of reduced total lung capacity
Source: Eur Respir J 2008; 31: 391-395
Year: 2008
Forced expiratory volume in one second (FEV
1
) and peak expiratory flow (PEF): is there a correlation in chronic obstructive pulmonary disease (COPD) patients?
Source: Eur Respir J 2001; 18: Suppl. 33, 213s
Year: 2001
Setting PEEP to abolish expiratory flow-limitation (EFL) for improving non-invasive mechanical ventilation (NIMV) in acute COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 818s
Year: 2006
Characteristics of patients with hypoxemic respiratory failure due to pneumonia that respond to the application of a positive end expiratory pressure
Source: International Congress 2016 – New horizons for noninvasive ventilation in acute and chronic settings
Year: 2016
The relationship between peak expiratory flow rate (PEFR) and forced expiratroy volume in the first second (FEV1) at low levels of FEV1. Implications for the assessment of COPD (chronic obstructive pulmonary disease) in primary care
Source: Eur Respir J 2002; 20: Suppl. 38, 397s
Year: 2002
Monocyte count and decline in forced vital capacity (FVC) in patients with IPF
Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Year: 2020
FEV6 or FVC to detect airway obstruction in the community setting?
Source: Annual Congress 2007 - PG17 - Lung function measurement in the community
Year: 2007
Should forced expiratory volume in six seconds replace forced vital capacity to detect airway obstruction?
Source: Eur Respir J 2006; 27: 1244-1250
Year: 2006
Expiratory and inspiratory vital capacities and the ventilatory pattern severity
Source: Virtual Congress 2020 – Lung function diagnostics
Year: 2020
Factors predicting change in interpretation in PFTs when using FVC vs. the largest measured vital capacity
Source: International Congress 2014 – Lung function testing: new findings and new approaches
Year: 2014
Predicted values for the forced expiratory flow adjusted for forced vital capacity, a descriptive study
Source: ERJ Open Res, 6 (4) 00426-2020; 10.1183/23120541.00426-2020
Year: 2020
Forced oscillation technique (FOT) in non-invasive ventilation (NIV) for treatment of expiratory flow limitation (EFL)
Source: International Congress 2019 – Treatment of acute respiratory failure with noninvasive ventilation
Year: 2019
Prediction of all cause mortality in a population sample is improved by using FEV
1
quotient
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005
Noninvasive mechanical ventilation (NIMV) improves the PaO
2
/FIO
2
ratio in patients with severe community acquired pneumonia
Source: Eur Respir J 2003; 22: Suppl. 45, 262s
Year: 2003
Dead space/tidal volume ratio (VD/VT) and pulmonary function (PF) in children with obstructive acute respiratory failure (OARF) on invasive mechanical pulmonary ventilation (IMPV)
Source: Eur Respir J 2004; 24: Suppl. 48, 676s
Year: 2004
Association between arterial-end-tidal PCO
2
difference [P(a - et)CO
2
] and dead space/tidal volume ratio (VD/VT) in children with obstructive acute respiratory failure (OARF) on invasive mechanical pulmonary ventilation (IMPV)
Source: Eur Respir J 2004; 24: Suppl. 48, 676s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept